Immunomodulators: use in combined therapy against leishmaniasis.
Dalton
Jane E
JE
Kaye
Paul M
PM
D000818:Animals; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007896:Leishmaniasis / Q000188:drug therapy*
D000981:Antiprotozoal Agents; D007155:Immunologic Factors